By Pam Belluck – Independent 02/13/2018
“… They are among the most challenging prostate cancer patients to treat: about 150,000 men worldwide each year whose cancer is aggressive enough to defy standard hormonal therapy, but has not yet spread to the point where it can be seen on scans. …”
Read the entire article: http://www.independent.co.uk/life-style/health-and-families/prostate-cancer-treatment-drugs-delay-spread-disease-apalutamide-enzalutamide-a8206151.html
